|
Diabetes, Vol 47, Issue 9 1472-1479, Copyright © 1998 by American Diabetes Association
Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus
F Ovalle, CG Fanelli, DS Paramore, T Hershey, S Craft and PE Cryer
Division of Endocrinology, Diabetes, and Metabolism, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
We tested the hypothesis that as few as two weekly brief episodes of
superimposed hypoglycemia (i.e., doubling the average frequency of
symptomatic hypoglycemia) would reduce physiological and behavioral
defenses against developing hypoglycemia and reduce detection of clinical
hypoglycemia in patients with type 1 diabetes mellitus (T1DM). Compared
with nondiabetic controls, six patients with well-controlled T1DM (HbA1c,
7.5 +/- 0.7% [mean +/- SD]) exhibited absent glucagon responses and reduced
epinephrine (P = 0.0027), norepinephrine (P = 0.0007), pancreatic
polypeptide (P = 0.0030), and neurogenic symptom (P = 0.0451) responses to
hypoglycemia as expected. In these patients, 2 h of induced hypoglycemia
(50 mg/dl, 2.8 mmol/l) twice weekly for 1 month, compared in a
random-sequence crossover design with an otherwise identical 2 h of induced
hyperglycemia (150 mg/dl, 8.3 mmol/l) twice weekly for 1 month, further
reduced the epinephrine (P = 0.0001) and pancreatic polypeptide (P =
0.0030) responses, tended to further reduce the norepinephrine and
neurogenic symptom responses to hypoglycemia, and reduced cognitive
dysfunction during hypoglycemia (P = 0.0271), all assessed in the
investigational setting. In the clinical setting, induced hypoglycemia did
not alter overall glycemic control, but did reduce the total number of
symptomatic hypoglycemic episodes detected by the patients from 49 to 30
per month and lowered the mean +/- SE self-monitored blood glucose level
during symptomatic hypoglycemia from 51 +/- 2 mg/dl (2.8 +/- 0.1 mmol/l) to
46 +/- 3 mg/dl (2.6 +/- 0.2 mmol/l) (P < 0.01). It also reduced the
proportion of low regularly scheduled self-monitored values that were
symptomatic by approximately 33%. Thus as little as doubling the frequency
of symptomatic hypoglycemia further reduced both the key epinephrine
response and clinical awareness of developing hypoglycemia, changes
reasonably expected to increase the risk of severe iatrogenic hypoglycemia
in T1DM.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. N. Zammitt, R. E. Warren, I. J. Deary, and B. M. Frier
Delayed Recovery of Cognitive Function Following Hypoglycemia in Adults With Type 1 Diabetes: Effect of Impaired Awareness of Hypoglycemia
Diabetes,
March 1, 2008;
57(3):
732 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Tkacs and H. J. Thompson
From bedside to bench and back again: research issues in animal models of human disease.
Biol Res Nurs,
July 1, 2006;
8(1):
78 - 88.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Inouye, J. T. Y. Yue, O. Chan, T. Kim, E. M. Akirav, E. Park, M. C. Riddell, E. Burdett, S. G. Matthews, and M. Vranic
Effects of Insulin Treatment without and with Recurrent Hypoglycemia on Hypoglycemic Counterregulation and Adrenal Catecholamine-Synthesizing Enzymes in Diabetic Rats
Endocrinology,
April 1, 2006;
147(4):
1860 - 1870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Cryer
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Diabetes,
December 1, 2005;
54(12):
3592 - 3601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Inouye, O. Chan, J. T. Y. Yue, S. G. Matthews, and M. Vranic
Effects of diabetes and recurrent hypoglycemia on the regulation of the sympathoadrenal system and hypothalamo-pituitary-adrenal axis
Am J Physiol Endocrinol Metab,
February 1, 2005;
288(2):
E422 - E429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Cryer
Diverse Causes of Hypoglycemia-Associated Autonomic Failure in Diabetes
N. Engl. J. Med.,
May 27, 2004;
350(22):
2272 - 2279.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Raju, V. P. McGregor, and P. E. Cryer
Cortisol Elevations Comparable to Those That Occur During Hypoglycemia Do Not Cause Hypoglycemia-Associated Autonomic Failure
Diabetes,
August 1, 2003;
52(8):
2083 - 2089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Cryer, S. N. Davis, and H. Shamoon
Hypoglycemia in Diabetes
Diabetes Care,
June 1, 2003;
26(6):
1902 - 1912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schultes, K. M. Oltmanns, W. Kern, H. L. Fehm, J. Born, and A. Peters
Modulation of Hunger by Plasma Glucose and Metformin
J. Clin. Endocrinol. Metab.,
March 1, 2003;
88(3):
1133 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. Paty, E. A. Ryan, A.M. J. Shapiro, J. R.T. Lakey, and R. P. Robertson
Intrahepatic Islet Transplantation in Type 1 Diabetic Patients Does Not Restore Hypoglycemic Hormonal Counterregulation or Symptom Recognition After Insulin Independence
Diabetes,
December 1, 2002;
51(12):
3428 - 3434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Inouye, K. Shum, O. Chan, J. Mathoo, S. G. Matthews, and M. Vranic
Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats
Am J Physiol Endocrinol Metab,
June 1, 2002;
282(6):
E1369 - E1379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Ryan, D. Dulay, C. Suprasongsin, and D. J. Becker
Detection of Symptoms by Adolescents and Young Adults With Type 1 Diabetes During Experimental Induction of Mild Hypoglycemia: Role of hormonal and psychological variables
Diabetes Care,
May 1, 2002;
25(5):
852 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. P. McGregor, J. S. Greiwe, S. Banarer, and P. E. Cryer
Limited Impact of Vigorous Exercise on Defenses Against Hypoglycemia: Relevance to Hypoglycemia-Associated Autonomic Failure
Diabetes,
May 1, 2002;
51(5):
1485 - 1492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Banarer, V. P. McGregor, and P. E. Cryer
Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response
Diabetes,
April 1, 2002;
51(4):
958 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Segel, D. S. Paramore, and P. E. Cryer
Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes
Diabetes,
March 1, 2002;
51(3):
724 - 733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sakurai, B. Yang, T. Takata, and K. Yokono
Synaptic Adaptation to Repeated Hypoglycemia Depends on the Utilization of Monocarboxylates in Guinea Pig Hippocampal Slices
Diabetes,
February 1, 2002;
51(2):
430 - 438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Cryer
Hypoglycemia-associated autonomic failure in diabetes
Am J Physiol Endocrinol Metab,
December 1, 2001;
281(6):
E1115 - E1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Sanders and S. Ritter
Acute 2DG-Induced Glucoprivation or Dexamethasone Abolishes 2DG-Induced Glucoregulatory Responses to Subsequent Glucoprivation
Diabetes,
December 1, 2001;
50(12):
2831 - 2836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Segel, C. G. Fanelli, C. S. Dence, J. Markham, T. O. Videen, D. S. Paramore, W. J. Powers, and P. E. Cryer
Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia
Diabetes,
August 1, 2001;
50(8):
1911 - 1917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. P. McGregor, S. Banarer, and P. E. Cryer
Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia
Am J Physiol Endocrinol Metab,
April 1, 2002;
282(4):
E770 - E777.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Diabetes Association.
|
|
| |
|